206 related articles for article (PubMed ID: 33977308)
1. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.
De Robertis R; D'Onofrio M; Zamboni G; Tinazzi Martini P; Gobbo S; Capelli P; Butturini G; Girelli R; Ortolani S; Cingarlini S; Pederzoli P; Scarpa A
Neuroendocrinology; 2016; 103(6):758-70. PubMed ID: 26646652
[TBL] [Abstract][Full Text] [Related]
3. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.
Kim DW; Kim HJ; Kim KW; Byun JH; Kim SY; Song KB; Ramaiya NH; Tirumani SH; Hong SM
Eur Radiol; 2016 May; 26(5):1320-9. PubMed ID: 26253259
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features.
Mori M; Palumbo D; Muffatti F; Partelli S; Mushtaq J; Andreasi V; Prato F; Ubeira MG; Palazzo G; Falconi M; Fiorino C; De Cobelli F
Eur Radiol; 2023 Jun; 33(6):4412-4421. PubMed ID: 36547673
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.
Park HJ; Kim HJ; Kim JH; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Eur Radiol; 2023 Apr; 33(4):2713-2724. PubMed ID: 36378252
[TBL] [Abstract][Full Text] [Related]
7. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
[TBL] [Abstract][Full Text] [Related]
9. Prediction of recurrence after surgery based on preoperative MRI features in patients with pancreatic neuroendocrine tumors.
Han S; Kim JH; Yoo J; Jang S
Eur Radiol; 2022 Apr; 32(4):2506-2517. PubMed ID: 34647178
[TBL] [Abstract][Full Text] [Related]
10. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
[TBL] [Abstract][Full Text] [Related]
11. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
12. Automatic Detection of Pancreatic Lesions and Main Pancreatic Duct Dilatation on Portal Venous CT Scans Using Deep Learning.
Abi Nader C; Vetil R; Wood LK; Rohe MM; Bône A; Karteszi H; Vullierme MP
Invest Radiol; 2023 Nov; 58(11):791-798. PubMed ID: 37289274
[TBL] [Abstract][Full Text] [Related]
13. Chronological improvement of pancreatectomy for resectable but advanced pancreatic neuroendocrine neoplasms.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K
Pancreatology; 2022 Dec; 22(8):1141-1147. PubMed ID: 36404199
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
[TBL] [Abstract][Full Text] [Related]
15. Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?
De Robertis R; Maris B; Cardobi N; Tinazzi Martini P; Gobbo S; Capelli P; Ortolani S; Cingarlini S; Paiella S; Landoni L; Butturini G; Regi P; Scarpa A; Tortora G; D'Onofrio M
Eur Radiol; 2018 Jun; 28(6):2582-2591. PubMed ID: 29352378
[TBL] [Abstract][Full Text] [Related]
16. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management-An Updated Review.
Bocchini M; Nicolini F; Severi S; Bongiovanni A; Ibrahim T; Simonetti G; Grassi I; Mazza M
Front Oncol; 2020; 10():831. PubMed ID: 32537434
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm.
Notake T; Shimizu A; Kubota K; Sugenoya S; Umemura K; Goto T; Yamada A; Fujinaga Y; Soejima Y
Langenbecks Arch Surg; 2024 Jan; 409(1):38. PubMed ID: 38221590
[TBL] [Abstract][Full Text] [Related]
19. CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms.
D'Onofrio M; Ciaravino V; Cardobi N; De Robertis R; Cingarlini S; Landoni L; Capelli P; Bassi C; Scarpa A
Sci Rep; 2019 Feb; 9(1):2176. PubMed ID: 30778137
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
